Ventyx Biosciences, Inc.
VTYX
$2.79
$0.145.28%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.99M | -27.44M | -29.35M | -35.25M | -31.95M |
| Total Depreciation and Amortization | 323.00K | 356.00K | 315.00K | 309.00K | 316.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.26M | 3.44M | 3.09M | 2.84M | 3.02M |
| Change in Net Operating Assets | 2.13M | -2.07M | 2.70M | -3.36M | 4.07M |
| Cash from Operations | -21.28M | -25.72M | -23.25M | -35.46M | -24.54M |
| Capital Expenditure | -42.00K | -16.00K | -6.00K | 0.00 | -60.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 25.23M | 26.43M | -10.99M | 29.25M | -75.46M |
| Cash from Investing | 25.19M | 26.42M | -11.00M | 29.25M | -75.52M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 68.00K | -- | 222.00K | 12.00K | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -906.00K |
| Issuance of Preferred Stock | -- | -- | -- | 26.85M | -- |
| Repurchase of Preferred Stock | -- | -- | -247.00K | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 68.00K | -- | -25.00K | 26.86M | -906.00K |
| Foreign Exchange rate Adjustments | 242.00K | 119.00K | -233.00K | 192.00K | -9.00K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 4.23M | 816.00K | -34.51M | 20.84M | -100.97M |